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Abstract:
Objectives - 
There is growing evidence for the use of biofeedback (BF) in affective 
disorders, dissocial personality disorder and in children with histories of 
abuse.  EEG markers could be used as neurofeedback in emotionally 
unstable personality disorder (EUPD) management especially for those at 
high risk of suicide when emotionally aroused.  This narrative review 
investigates the evidence for electroencephalogram (EEG) markers in 
EUPD. 
Methods - 
PRISMA guidelines were used to conduct a narrative review. A structured 
search method was developed and implemented in collaboration with an 
information specialist. Studies were identified via three electronic 
database searches of Medline, Embase and psychINFO.  A predesigned 
inclusion/exclusion criterion was applied to selected papers. A thematic 
analysis approach with five criteria was used. 
Results - 
From an initial long list of 5250 papers, 229 studies were identified and 
screened, of which 44 met at least three of the predesigned inclusion 
criteria.  No research to date investigates EEG-based neurofeedback in 
EUPD. A number of different EEG biomarkers are identified but there is 
poor consistency between studies.   
Conclusions - 
The findings heterogeneity may be due to the disorder complexity and 
the variable EEG related parameters studied. An alternative explanation 
may be that there are a number of different neuromarkers, which could 
be clustered together with clinical symptomatology, to give new sub-
domains. Quantitative EEGs in particular may be helpful to identify more 
specific abnormalities. EEG standardization of neurofeedback protocols 
based on specific EEG abnormalities detected may facilitate targeted use 
of neurofeedback as an intervention in EUPD. 
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There is growing evidence for the use of biofeedback (BF) in affective disorders, dissocial 
personality disorder and in children with histories of abuse.  EEG markers could be used as 
neurofeedback in emotionally unstable personality disorder (EUPD) management especially 
for those at high risk of suicide when emotionally aroused.  This narrative review investigates 
the evidence for electroencephalogram (EEG) markers in EUPD.
Methods -
PRISMA guidelines were used to conduct a narrative review. A structured search method was 
developed and implemented in collaboration with an information specialist. Studies were 
identified via three electronic database searches of Medline, Embase and psychINFO.  A 
predesigned inclusion/exclusion criterion was applied to selected papers. A thematic analysis 
approach with five criteria was used. 
Results -
 From an initial long list of 5250 papers, 229 studies were identified and screened, of which 
44 met at least three of the predesigned inclusion criteria.  No research to date investigates 
EEG-based neurofeedback in EUPD. A number of different EEG biomarkers are identified 
but there is poor consistency between studies.  
Conclusions -
The findings heterogeneity may be due to the disorder complexity and the variable EEG 
related parameters studied. An alternative explanation may be that there are a number of 
different neuromarkers, which could be clustered together with clinical symptomatology, to 
Page 3 of 66
http://mc.manuscriptcentral.com/eeg































































give new sub-domains. Quantitative EEGs in particular may be helpful to identify more 
specific abnormalities. EEG standardization of neurofeedback protocols based on specific 
EEG abnormalities detected may facilitate targeted use of neurofeedback as an intervention in 
EUPD. 
KEY WORDS:
Emotionally unstable personality disorder; Borderline personality disorder; 
Electroencephalogram; Neurofeedback; Neuromodulation
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Emotionally Unstable Personality Disorder - 
Emotionally unstable personality disorder (EUPD) is one of ten personality disorders defined 
in the ICD classification system.1 It is a complex disorder characterised by pervasive 
instability of interpersonal relationships, self-image, mood and impulsive behaviour. There is 
a pattern of rapid fluctuation from periods of confidence to despair, with fear of abandonment 
and chronic feelings of emptiness. Transient psychotic symptoms including brief delusions 
and hallucinations may also be present. There is a strong tendency towards suicidal thinking 
and self-harm. People with EUPD are at high risk of suicide with 60 to 70% attempting 
suicide at some point and a completed suicide rate of 10%.2,3
Along with psychosocial and functional impairment, EUPD is associated with significant 
financial cost to the healthcare system, social services and wider society,4,5 especially when 
in an emotional crisis or aroused state. The National Institute of Health and Clinical 
Excellence (NICE) guidelines for the management of EUPD advise frequent risk assessment 
and management, psychological treatments, medications for management of comorbidities 
and short-term medication use in crisis.6 However, there are few drugs or interventions 
recommended specifically for EUPD or the individual symptoms or behaviour associated 
with the disorder. Any newer or additional treatment options would be welcome in the 
management of EUPD, particularly for those in the aroused state.
Electroencephalogram and psychopathology - 
The relationship between changes on the electroencephalogram (EEG) and psychopathology 
has long been recognised (Table 1).7-14
Page 5 of 66
http://mc.manuscriptcentral.com/eeg































































There is also evidence for the impact of psychotropic medications on alpha, beta, delta and 
theta waves of the EEG.11-15
Evidence for EEG based neurofeedback in psychiatric disorders 
A study examined the relationship between distribution patterns of epileptiform discharges 
(ED) and clinical symptoms across affective, cognitive, and somatic domains.16 In a sample 
of 71 nonepileptic psychiatric patients, those with EDs appearing in homologous electrode 
pairs endorsed significantly fewer symptoms related to affective deregulation. Conversely, 
patients with isolated EDs focused to a single brain region endorsed greater affective 
deregulation and severe clinical symptoms. These factors suggest that a carefully recorded 
and analysed EEG could be used to identify neuromarkers for many non-epileptic psychiatric 
disorders.
Various EEG changes have been observed in psychiatric disorders. Increased slow wave 
activity has been demonstrated in those with depression, OCD, autism and ADHD.17,18 
Posterior sharp waves have been seen in a range of psychiatric disorders.19 Applying modern 
network theory to EEG and fMRI studies of people with schizophrenia has shown loss of 
functional connectivity and increased randomness of the networks compared to controls.20 
Intermittent rhythmic delta and theta activity have been shown in a range of disorders,21 and 
alterations in gamma synchrony have been demonstrated in schizophrenia, in particular under 
resting conditions and in the auditory evoked state.22 During processing of neutral stimuli, 
subjects with an anxiety disorder may have a shorter latency of P300 and higher amplitude of 
event-related potentials compared to controls.23 
There is growing evidence for EEG changes in dissocial personality disorder.24-28 Gender 
differences in psychopathology presentation show that males under similar conditions display 
a higher level of externalising (including dissocial behaviour disorders) and females a higher 
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level of internalising (including EUPD) symptoms,29-31 suggesting that changes evident in 
dissocial personality disorder may also be applicable in EUPD. Furthermore, early childhood 
sexual and psychological abuse and early stress have been linked to increased 
electrophysiological abnormalities.32-35 Such early life experiences are associated with 
EUPD. Thus, electrophysiological changes may also exist in EUPD. 
Researchers have been examining the possibility of using biofeedback (BF) as a treatment for 
affective disorders,36,37 and in other areas of psychiatry9,38,39. A recent systematic review 
investigated various modalities of BF for psychiatric disorders.9 Of the EEG BF articles 
reviewed, fourteen (70.0 %) studies reported statistically significant clinical amelioration 
following EEG BF exposure. Mean number of sessions per study was 23.7 (range 5–69), with 
BF exposure lasting 28.7 min (range 14.6–60 min) on average per session. Different types of 
neurofeedback therapy were utilised in the studies including alpha regulation neurofeedback, 
alpha-theta regulation feedback, alpha-asymmetry regulation, theta feedback, alternating 
theta decrease/beta increase neurofeedback, slow cortical potential neurofeedback and qEEG 
(quantitative EEG) guided BF. QEEG is an emerging form of neurofeedback, which applies 
mathematical and statistical analysis to EEG brainwaves, and compares them to age and 
gender controlled databases of individuals with no known brain dysfunction. Recently qEEG 
neurofeedback has been used therapeutically in the treatment of dissocial personality 
disorder.40 QEEG guided neurofeedback has been shown to have medium size effect in 
improving attention and reducing behavioural, emotional and social problems of children 
with histories of abuse and neglect.41 Other components of neurofeedback therapy such as the 
number of channels used for EEGs, number and duration of neurofeedback sessions may also 
represent important considerations for neurofeedback protocols.
Evidence for neurofeedback in EUPD and other psychiatric disorders using 
neuroimaging and neurofeedback training 
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More recently, evidence for neurofeedback in EUPD has emerged. A proof of concept study 
for fMRI-based neurofeedback in complex emotional states preliminarily validates the notion 
that individuals can experience powerful emotional states and recruit relevant brain networks 
in real time using a neurofeedback tool.42 Furthermore, amygdala neurofeedback via fMRI 
has been associated with successful down-regulation of right dorsal amygdala activation in 
patients with EUPD.43  There was also evidence for reduced dissociative experiences and 
improvements in emotion regulation in those with EUPD. Such results demonstrate that 
neurofeedback may improve abnormalities found on MRI and emotion regulation in patients 
with EUPD. However further validation is required. 
Neurofeedback therapy generally utilises specific targets dependent on the disorder. A 
common target of EEG neurofeedback in major depressive disorder is an increased spectral 
power in the alpha band on the left and a decreased spectral power in the alpha band on the 
right fronto-central cortex.39,44 Along with depressive disorder, EEG alpha asymmetry has 
also been shown in individuals with schizophrenia.45 The theta/beta protocol where the goal 
is to decrease brain activity in the theta band and increase brain activity in the beta band at 
the vertex is the most commonly used EEG-based neurofeedback therapy in ADHD. A 
common goal of neurofeedback for treatment of psychiatric symptoms in children with 
autism is to inhibit the theta-alpha ratio while enhancing beta waves.46 Theta neurofeedback 
training may also have potential benefits in treatment of generalized anxiety disorder.47
The growing research on EEG neurofeedback for affective disorders,36,37,39-44 dissocial 
personality disorder,40 and in children with histories of abuse,41 raises consideration as to 
whether similar evidence has been explored for EUPD.  The strength of any such evidence 
and whether such deliberations can further specific investigation and treatments in this 
modality for EUPD is examined in this paper. 
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There is evidence for fMRI neurofeedback in EUPD, but there has been no research to date 
which examined EEG-guided neurofeedback in EUPD.  EEG-guided neurofeedback is likely 
to be easier to complete and can be made more widely available compared to fMRI guided 
neurofeedback. 
Aim -
1. This review looks to appraise the evidence to date for EEG changes in EUPD and in 
arousal states of EUPD 
2. To identify if the evidence for EEG changes in EUPD has provided any management 
strategies.  
3. The review aims to consider if neurofeedback using EEG changes as a potential 
intervention for EUPD is a viable option.
METHODS:
The protocol for this review followed PRISMA guidance (appendix 3).48
Search strategy and selection criteria -
References for this review were identified through searching Medline, PsycInfo and Embase 
using the search terms “EUPD” and “arousal” and “EEG” along with associated terms as per 
the search terms in Appendix 1.  All articles available up until the final database search in 
February 2018 which had an English language translation available, were included. The 
search was conducted by two authors and independently verified by a third author.  
After removal of duplicates, articles that were not relevant to the review were removed 
following review by two authors i.e. not referring to electrophysiological investigation/ 
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biological markers in personality disorder, affective disorders, general psychopathology or 
associated terms. Two authors then applied the following prearranged inclusion criteria to all 
abstracts;
1) The article refers to EUPD / Borderline Personality Disorder (BPD) as the primary 
diagnosis
2)  Must be a case-control/ cohort/ cross sectional study or higher on the hierarchy of 
evidence. 
3)  The population under investigation were all over 18 years of age
4)  EEG was the only or main investigation of the study and the article referred to EUPD.
5)  The article refers to EEG changes during emotional fluctuations.
Articles fulfilling less than three of the inclusion criteria were excluded. Reference lists of 
potentially eligible papers were manually searched for additional citations and a grey 
literature search was performed. A second author confirmed included studies and a final list 
of included articles was developed, as per pathway 1 (see appendix 1 and 2 for full search 
outline). 
RESULTS:
Following the database search, 5250 studies were assessed for eligibility. An additional 155 
studies were included following a search of the grey literature, reference lists and checking 
whether eligible studies were cited elsewhere. Articles were excluded at each stage as per 
Pathway 1 and methods (as above). Of the 44 articles which met three or more criteria, two 
papers met five criteria,49,50 26 papers met four criteria,51-76 and 16 papers met three 
criteria.34,41,79-88,90,93
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Data on study size, population/ problem, intervention, comparisons, outcomes, setting and 
bias were examined. Diagnostic system used and use of sub domains of EUPD i.e. impulsive 
vs. borderline type were also examined. The articles were sorted according to the number of 
criteria fulfilled in an attempt to highlight the relative importance of individual articles to our 
review as per the search criteria. 
Articles meeting Five Criteria - 
Two articles met all five search criteria (table 2).49,50
Both of these studies had control groups (with depression and healthy controls) but had only 
female subjects and did not control for medications or comorbidities. These two papers 
established “greater left cortical activation” and “higher total theta power” respectively on 
EEG during arousal in people with EUPD compared to those with depression and healthy 
controls. However both studies were of small sample size, referred to specific incidences of 
high arousal and provided limited evidence for the above changes. The EEG parameters that 
were explored were different in both studies and hence cannot be combined or compared.
Articles meeting Four Criteria (Arranged into a review article, articles using standard 
EEGs, sleep EEGs and evoked potentials) - 
One review article, which met four of our search criteria, was identified. Boutros et al. 
examined 26 articles on electrophysiological techniques in EUPD, including one review and 
25 original research articles.51 The authors performed MEDLINE and PsycInfo searches 
between 1966 to 2000 for “biological aspects” and “BPD”. They also performed additional 
searches using the terms EEG, evoked potentials (EP), sleep and polysomnography (PSG) 
and a search of referenced articles. 
The reviewers highlight a high prevalence of electrophysiological aberrations in EUPD (such 
as shortened REM latency on polysomnography and diminution of P300 amplitude in evoked 
potential studies). They also highlight the heterogeneity between articles due to ambiguity of 
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diagnostic criteria and lack of control for comorbidity and pharmacotherapy. The reviewers 
conclude that existing literature represents a preliminary stage in the field and suggest a need 
for further research combining different electrophysiological test modalities. Various types of 
EEG were reviewed including standard scalp EEG, sleep EEG and evoked potentials. The 
search used was for the period 1966 to 2000. All the studies met criteria 1,2,3 and 4, but none 
of the studies identified a specific EEG change due to arousal fluctuations and thus did not 
meet criteria five. 
The following 25 papers, which met four criteria, are presented by integrating them into key 
themes based on the type of EEG used to aid interpretation of results. 
Articles using Standard EEGs -
 Eight articles, which used standard EEGs and met four search criteria, were identified (Table 
3).52-59
 The main findings include correlation of impulsiveness with EEG abnormalities (positive 
spikes in patients with high scores for impulsivity),52 diffuse slowing,53 dysrhythmias,54 non-
focal sharp waves, especially in posterior areas,55 spike-wave discharges or a clear excess of 
sharp waves, increased slow wave activity,56 less stable vigilance pattern with a tendency to 
drop to lower vigilance states,57 increased prevalence of intermittent rhythmic delta (IRDA) 
or theta (IRTA) activity,58 random or semi-rhythmic theta and/or delta, and abnormalities in 
temporal lobe areas.59 Six of the studies had control groups and four of these discussed 
significant EEG abnormalities in those with EUPD. However only three of the studies 
adequately controlled for co-morbid conditions.52,55,58 Two studies included a healthy control 
group,57,58 one study included a control group for those with depression,55 and one study a 
control group for non-EUPD personality disorders.52 Half of the studies used clinical 
assessment to establish diagnosis (Table 3).55,57-59
Articles using sleep EEGs -
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Ten articles on sleep EEGs that met four of the search criteria were identified (Table 4).60-69 
None of these articles met criteria five (i.e. refer to EEG changes between baseline and an 
arousal state). 
The findings from sleep EEG based studies include increased REM percentage,60 increased 
REM density,60,61 shorter REM latency,60,62-66 (much shorter in EUPD with Depression),63 
longer REM period,60,67,68 no difference in conventional polysomnography, but increased 
delta power in Non-REM sleep in spectral analysis,69 reduced slow wave, stage 3 & 4  
sleep.67,68 The most frequent abnormality found in the above studies was of reduced REM 
latency compared to healthy controls (six out of ten studies) and in some cases compared to 
other control groups. However there was no difference between the EUPD and depressed 
groups,64 or the changes were more robust in those with depression.60 Nine of the studies 
included healthy controls as a comparison and one study did not.63 Three of the studies 
included patients with co-morbid depression in the sample with EUPD,63,64,66 and two of the 
studies included patients with a history of substance misuse.61,62 The studies discussed all had 
small sample sizes (8 – 24 patients with EUPD) and  diagnosis was made with structured 
measures in 7 studies.61,62,64,66-69 Four of these studies64,66-68 used DIB as a diagnostic measure 
and clinical criteria were used in 3 studies.60,63,65 Aside from one study,63 all of the other 
studies had at least 10-14 days of prior psychotropic medication free period.
Articles using Evoked potentials -
7 articles using evoked potentials, which met at least four of the search criteria, were 
identified (Table 5).70-76 
None of these studies met criteria 5 (i.e. did not refer to EEG changes between an aroused 
and resting state). Of the seven studies, five used structured diagnostic criteria70,74 and two 
relied on clinical criteria.75,76 All seven studies had healthy control groups and four studies 
had additional subjects with other psychiatric conditions.70-72,76 There were no comorbidities 
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or at least no affective comorbid conditions in five studies, and two studies did not report on 
comorbidities.73,76 The studies had only70,74 or mainly71,73,75,76 female subjects, two studies 
were on subjects who were medication free for at least one week75 and 30 days73 respectively, 
while others had mixed groups with either no medication or on various psychotropics. Four 
studies consistently highlight decreased amplitude and prolonged latency of P300 during 
oddball paradigms/ auditory discrimination tasks in those with EUPD compared to 
controls.70-72,75 However, these changes were shown to be similar to those seen in 
schizophrenia71 and schizotypal personality disorder72 One further study illustrated 
differences in distinct components of P300 during  an oddball paradigm/ two-tone auditory 
detection test between those with EUPD and healthy controls.73 Such changes highlight a 
specific EEG abnormality in response to an unexpected stimulus. One study reported larger 
late positive potential (LPP) to unpleasant stimuli.74 No difference in effect of facial emotion 
on ERP was reported in one study.76 The studies reviewed do not investigate P300 
specifically in relation to emotional fluctuations. 
Articles meeting 3 Criteria 
Articles meeting Criteria 1, 2 and 4 
Three studies met criteria 1, 2 and 4 (Table 6).77-79 Two of these studies used structured 
diagnostic criteria.77,78 There were two studies (same authors in both) with EUPD–free 
adolescents in the control group.77,78 All three studies were on medication free subjects. One 
study involved people with no comorbidities,79 one had depression and conduct disorder as 
comorbidities,77 while another did not report significant psychiatric comorbidity.78 One study 
found no significant difference in wake and sleep EEGs between patients with EUPD, non-
EUPD personality disorder, dysthymic disorder and “mixed psychiatric diagnosis”.79 Another 
study examining evoked potentials showed that there were no age-related changes in P300 
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amplitude (i.e. reduction in P300 amplitude with age) in adolescents with EUPD traits as 
compared to normal control subjects.77 These findings suggest altered brain maturation in 
adolescents with emerging EUPD. However, a similarly designed case control study 
examining evoked potentials showed contrasting findings of reduction in P300 amplitude 
with age in adolescents with EUPD compared to controls.78 The findings of reduced P300 
amplitude in EUPD are in keeping with earlier reported findings.70-72,75
Articles meeting criteria 1, 2 and 3
Six studies met criteria 1, 2 and 3 (Table 7).80-85 Of these, two studies used clinical 
criteria,80,81 and four used structured instruments82-85 to establish diagnosis. Five were case-
controlled studies with four studies having healthy controls80,82,84,85 and one was a cohort 
study.83 There were no comorbidities or comorbidities were not reported. The findings in 
these studies include that those with EUPD have significantly higher loudness dependence of 
the N1/P2 component of auditory evoked potentials,80 mean frequency on spectral analysis 
correlated with anxiety levels after both placebo and amphetamine challenge,82 and that 
standard waking scalp EEG and TSH (thyroid stimulating hormone) influence sleep EEG, 
neurological soft signs and post dexamethasone cortisol levels.83 Having an abnormal EEG 
increases the probability of patients with EUPD having less slow wave sleep, the opposite of 
which is seen in EUPD patients with a normal EEG.  Five biological tests including TSH, 
standard waking scalp EEG, sleep EEG, post dexamethasone cortisol levels and neurological 
soft signs were shown to be interconnected and interdependent. Other findings include 
reduced P3 amplitudes during No-go responses in EUPD,84 enhanced activation of the 
orbitofrontal cortex following an unexpected reward in EUPD patients with NSSI85 and 
significant delay in early posterior gamma synchrony and a reduction in right hemisphere late 
gamma synchrony in response to salient stimuli in EUPD.81 In the final study, the authors 
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conclude that EUPD is characterised by specific disturbances in neural synchrony related to 
core symptoms of cognitive impairment and impulsivity.
Articles meeting criteria 1, 3 and 4
One case study (Table 8) focused on QEEG changes in a patient with EUPD.86 QEEG can 
provide functional information necessary to facilitate neurofeedback through engaging the 
brain to normalize dysfunctional brain wave patterns.87 The article showed a mild to 
moderate increase in slow wave frequencies (theta, delta and slow alpha) in the orbital cortex, 
dorsomedial prefrontal and dorsolateral prefrontal cortices and a decrease of fast wave 
activities in the participant compared to normative data. The findings suggest a starting point 
for using QEEG as a means of investigating the potential role of neurofeedback in EUPD. 
Articles meeting criteria 2, 3 and 4
Five studies met criteria 2, 3 and 4 (Table 9).34,88-91 Of these, three studies used clinical 
criteria34,88,89 and two studies used structured instruments90,91 to make the diagnosis. All five 
studies were case-control studies with healthy control groups, while two studies had 
additional groups with other psychiatric diagnosis.89,91 Three studies did not report on 
medication34,90,91 and two studies were on those receiving antidepressants/anxiolytics.90,91 
One study had depression as a comorbidity90 and others had no comorbidities. The findings in 
these studies included bimodal distribution of dominant frequencies and higher incidence of 
beta activity in psychoneurotic patients,88 smaller late positive component (LPC) amplitude, 
P300 latency  and P300 amplitudes when making incorrect responses to emotional pictures 
and faces;90 there was no significant difference between groups when making correct 
responses to emotional cues. This article included participants who endorsed EUPD traits (i.e. 
endorsing a score >7 on the McLean Screening Instrument)92 rather than meeting full 
diagnostic criteria. However the authors suggest that people who meet the full diagnostic 
criteria are likely to exhibit larger differences in evoked-potential response than those in this 
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study. Of note, the findings of decreased P300 amplitude are consistent with research 
reported earlier in this paper, but shorter P300 latencies contrast with previously reported 
findings.  
A study found reduced P3 amplitude in those with treatment resistant depression and 
generalised anxiety disorder compared to healthy controls and those with EUPD.89 A study 
on children with a history of abuse found greater average left hemisphere coherence and a 
greater number of abnormal EEGs.34 A study found no significant difference in event-related 
potentials in response to a single tone between patients with EUPD, non-EUPD personality 
disorders and healthy controls.91
Articles meeting criteria 2, 4 and 5
One study met criteria 2,4 and 5 (Table 10) and showed evidence for qEEG-guided 
neurofeedback in children with histories of abuse and neglect.41 This clinical trial showed a 
significant reduction in scores on the Childhood Behaviour Checklist93 following qEEG-
guided neurofeedback. A significant link exists between abuse and neglect in early childhood 
and a diagnosis of EUPD. These results point towards the potential role of qEEG-guided 
neurofeedback for patients with EUPD. 
Of the articles which met three criteria, 11 showed EEG abnormalities in those with EUPD 
compared to controls. Furthermore, two articles showed EEG abnormalities in children with 
histories of abuse and one article demonstrated EEG abnormalities in “psychoneurosis”. 
DISCUSSION:
We have conducted a comprehensive review illustrating the evidence to date for EEG 
markers in EUPD, especially in the aroused state. This paper reviewed 44 papers according to 
specific search criteria. Our findings indicate a variety of possible EEG changes present in 
EUPD. However, there were only two studies which referred to changes between baseline 
and a high arousal state.49,50 The EEG findings of “greater left cortical activation” in EUPD in 
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response to rejection49 and “higher total theta power” in response to pain in those with BPD-
NP50 are not specific to EUPD; higher alpha power in the left fronto-central cortex has been 
demonstrated in major depressive disorder39,44 and increased theta activity has been utilised in 
neurofeedback therapy in ADHD, autism and anxiety.45-47 Five studies consistently highlight 
differences in components of P300 during oddball paradigms/ auditory discrimination tasks 
in those with EUPD compared to controls.70-73,75 Arousal levels have previously been shown 
to effect the availability of attention processes to modulate P300,94,95 suggesting a need for 
further investigation of P300 in a state of high arousal in EUPD.
More than half of the studies examining standard waking EEGs in EUPD highlighted 
significant EEG abnormalities compared to controls (Table 11). All these findings can 
potentially be seen in other disorders.17-22 Half of the sleep EEG studies identified reduced 
REM latency as an EEG biomarker in EUPD. However, abnormalities detected on sleep EEG 
cannot be used in potential EEG based neurofeedback treatments. Half of the studies on event 
related potentials highlight decreased amplitude and prolonged latency of P300 in those with 
EUPD compared to controls, similar to the potential EEG changes seen in anxiety.23 P300  
amplitude and latency may represent a neuromarker in EUPD.
It is also worth noting that the studies reviewed used varying protocols for type of EEG, 
number of channels and electrode placement. Three of the studies did not specify type of 
EEG used, site of electrode placement was not specified in 14 studies, 13 studies did not 
specify number of channels used and 24 studies did not specify whether artefacts were 
removed. Other limitations to the studies reviewed include small sample size, mainly female 
participants, medication use and the presence of comorbid disorders.
Although not consistent between studies, various EEG abnormalities in subgroups of patients 
with EUPD were identified. None of the EEG findings are specific to EUPD or any other 
specific disorders. However, if corroborated by further evidence, these findings may 
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potentially be used as neuromarkers and targets for neurofeedback in the treatment of aroused 
states in EUPD.  One possibility is that EEG neuromarkers particular to EUPD only exist 
whilst in a specific state (e.g. high arousal). Alternatively there may be a number of different 
neuromarkers which could be clustered together with subdomains of EUPD or clinical 
symptomatology. This may help in identifying subdomains of patients and person-centred 
tailored treatments for them. 
There was no study to date which investigated the potential role of EEG based neurofeedback 
as an intervention in EUPD. However, advances in qEEG data may improve the detection of 
EEG abnormalities in psychiatric disorders and thus the potential for neurofeedback 
therapy.96 Use of neurofeedback therapy in EUPD based on these EEG markers may result in 
clinical amelioration of symptoms as in other psychiatric disorders.9
CONCLUSION:
Due to the limited evidence to date, specific conclusions on EEG changes during changes in 
arousal in EUPD or the potential mapping of EEG findings to EUPD subdomains cannot be 
drawn. Further study into the mapping of neuromarkers with EUPD subdomains and clinical 
symptomatology could define targeted use of neurofeedback as a potential intervention in this 
disorder. Based on the findings in this review, a checklist of EEG findings commonly found 
in those with EUPD has been developed (appendix 4). The mechanism of its development has 
been provided (appendix 5).This checklist could be used to design and conduct further studies 
in this area so as to confirm or rule out the identified cumulative findings as neuromarkers of 
EUPD. There is evidence for using neurofeedback in a number of psychiatric conditions and 
our review highlights a number of EEG markers in EUPD. Hence we believe that with further 
research verification, EEG-based neurofeedback treatment options, especially for individuals 
in the aroused state could be developed.
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Pathway 1: Search and selection criteria 
Search and elimination process 
Records identified through 
database searching           
(n= 5250)
Records identified through 
other sources i.e. grey 
literature, reference lists, 
cited by references (n= 155)
Records after duplicates 
removed (n= 3253)
Records Screened   
(n = 3253)
Articles selected as 
potentially relevant to 
our review   (n = 229)
Full text articles assessed & 
included in the review (n = 44)
Studies meeting 5 Criteria (n= 2), 4 
criteria (n = 26), 3 Criteria (n= 16)
Records excluded on 
initial screening             
(n = 3024)
Articles meeting  
< 3 criteria           
(n =  185)
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Emotionally Unstable Personality Disorder (EUPD): The diagnostic term EUPD is used 
throughout the article to represent both Emotionally Unstable Personality Disorder (ICD-10 
F60.30 Impulsive type and F60.31 Borderline type) and Borderline Personality Disorder 
(DSM IV 301.83). We have retained the term EUPD throughout the article for consistency. 
Where the term BPD is used this is to highlight diagnostic systems used and specific terms 
used in the original article.
Dysrhythmia: EEG cerebral dysrhythmia denotes isolated episodic paroxysmal bursts of slow 
activity, controversial/anomalous spiky waveforms and/or true non-controversial epileptiform 
discharges
Search terms -
(“eupd” OR “borderline disorder” OR “borderline patient” OR “borderline condition” OR 
“borderline client” OR "borderline personality" OR "borderline personalities” OR “bpd” OR 
“borderline state” OR “affective instability” OR  "personality disorder" OR "personality 
disorders” OR "PERSONALITY DISORDERS" OR "ANTISOCIAL PERSONALITY 
DISORDER" OR "BORDERLINE PERSONALITY DISORDER” OR “antisocial 
personalities" OR "antisocial personality” OR “anti-social personalities" OR "anti-social 
personality” OR “sociopath” OR “psychopath” OR “psychoneurotic” OR “psychoneuros*” 
OR “impulsivity” OR “impulse control” OR “multi-impulsivity OR multi-impulsive” OR 
“character disorder” OR “impulsive behaviour" OR "impulsive behavior” OR "IMPULSIVE 
BEHAVIOR” OR "DISRUPTIVE, IMPULSE CONTROL, AND CONDUCT DISORDERS” 
OR “post traumatic" OR “posttraumatic” OR “ptsd” OR "STRESS DISORDERS, POST-
TRAUMATIC” OR “dyssocial” OR “socio-path”)
AND
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(“ AROUSAL” OR “arousal” OR “arouse” OR “aroused” OR “vigilance” OR “rest state" OR 
"resting state” OR “rest states” OR “resting states” OR "acute phase” OR “abnormal”  OR 
“abnormality “ OR “abnormalities” OR “crisis” OR “crises” OR “distress” OR “distressed” 
OR “agitated” OR “agitation” OR "PSYCHOMOTOR AGITATION” OR “panic” OR 
“PANIC” OR “depressed” OR “depression” OR “depressive” OR “DEPRESSION”)
AND
(“eeg” OR “electroencephalogram” OR “electroencephalograms” OR “electrograph*” OR 
“electrograms” OR “electrogram” OR “electroencephalograph” OR “ 
ELECTROENCEPHALOGRAPHY” OR "BRAIN WAVES” OR “ TELEMETRY” OR 
“telemetry” OR “ptsw” OR “slow wave" OR "slow waves” OR “p300” OR "EVENT-
RELATED POTENTIALS” OR “P300” OR “EVOKED POTENTIALS” OR 
"CONTINGENT NEGATIVE VARIATION”  OR “EVENT-RELATED POTENTIALS” OR 
“orbito-frontal” OR “orbitofrontal” OR “qeeg” OR “p3a” OR p3b” OR “evoked potential*” 
OR “event related potential*” OR “Bereitschaftspotential” OR "readiness potential” OR 
“cnv” OR "contingent negative variation”” OR “brain wave*” OR “alpha wave*” OR “beta  
wave*” OR “delta wave*” OR “gamma wave*” OR “theta wave*” OR “alpha rhythm*” OR 
“beta rhythm*” OR “delta rhythm*” OR “gamma rhythm*” OR “rhythm wave*”)
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1) Online database search using Medline, PsycInfo and Embase. 
2) Search for grey literature.
3) Review of the references of articles meeting three or more criteria (see below) 
4) Search of particularly relevant articles meeting three or more criteria for “cited by” 
references in Pubmed, Scopus and Google Scholar.
 5) Contacting authors of relevant articles about any unpublished articles/ results.                                            
There were no language limits in the search strategy, provided there was an English language 
translation of the relevant study available. 
Data Sources:
Appendix 1 shows the search strategy for Medline on Healthcare Databases Advanced Search 
(HDAS) using a combination of text words and thesaurus terms. The same strategy was used 
for PsycInfo and Embase but thesaurus terms specific to the different databases were used. 
Other databases were searched for grey literature using an appropriately amended strategy. 
The number of articles from each database is indicated in Table 12. 
All articles published before the final database search in February 2018 were included. 
Step 1
Any articles duplicated during the collection process were removed. Articles that were not 
relevant to the review were removed i.e. not relevant to electrophysiological investigation/ 
biological markers in personality disorder, affective disorders, general psychopathology or 
associated terms. 
Step 2
The first and final authors applied the prearranged inclusion criteria to all abstracts.
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1) The article refers to EUPD / Borderline Personality Disorder (BPD) as the primary 
diagnosis
2)  Must be a case-control/ cohort/ cross sectional study or higher on the hierarchy of 
evidence. 
3)  The population under investigation were all over 18 years of age
4)  EEG was the only or main investigation of the study. Articles meeting criteria 4 must also 
refer to EUPD or equivalent terms.
5)  The article refers to EEG changes during emotional fluctuations. 
Step 3
Articles that met three or more of the above criteria were fully reviewed.
Citation searching -
Checks were made to ascertain whether particularly relevant articles (i.e. articles meeting 
three or more criteria) were cited elsewhere. 
Reference Lists -
The reference list of each article screened as eligible was checked for additional articles not 
included through other search methods.
Contact with Authors -
Authors of articles meeting three or more criteria and included in this review were contacted 
to check if additional articles or any unpublished articles/ results were available. 11 authors 
of particularly relevant articles were contacted by email. Responses were received from four 
of these authors, none of whom were aware of additional unpublished studies/ results.
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Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for 
Scoping Reviews (PRISMA-ScR) Checklist
SECTION ITEM PRISMA-ScR CHECKLIST ITEM REPORTED ON PAGE #
TITLE




Provide a structured summary that includes (as 
applicable): background, objectives, eligibility 
criteria, sources of evidence, charting methods, 





Describe the rationale for the review in the context 
of what is already known. Explain why the review 




Provide an explicit statement of the questions and 
objectives being addressed with reference to their 
key elements (e.g., population or participants, 
concepts, and context) or other relevant key 






Indicate whether a review protocol exists; state if 
and where it can be accessed (e.g., a Web 
address); and if available, provide registration 
information, including the registration number.
NA
Eligibility criteria 6
Specify characteristics of the sources of evidence 
used as eligibility criteria (e.g., years considered, 





Describe all information sources in the search 
(e.g., databases with dates of coverage and 
contact with authors to identify additional sources), 




Present the full electronic search strategy for at 
least 1 database, including any limits used, such 






State the process for selecting sources of 
evidence (i.e., screening and eligibility) included in 
the scoping review.
8-9 and 




Describe the methods of charting data from the 
included sources of evidence (e.g., calibrated 
forms or forms that have been tested by the team 
before their use, and whether data charting was 
done independently or in duplicate) and any 
processes for obtaining and confirming data from 
investigators.
8-9 and 
pathway 1 and 
appendix 1
Data items 11
List and define all variables for which data were 
sought and any assumptions and simplifications 
made.
Tables 2 to 10
Critical appraisal 
of individual 12
If done, provide a rationale for conducting a critical 
appraisal of included sources of evidence; 
describe the methods used and how this 
9 to 16
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SECTION ITEM PRISMA-ScR CHECKLIST ITEM REPORTED ON PAGE #
sources of 
evidence§




Describe the methods of handling and 






Give numbers of sources of evidence screened, 
assessed for eligibility, and included in the review, 
with reasons for exclusions at each stage, ideally 
using a flow diagram.
9 to 16 and 





For each source of evidence, present 




within sources of 
evidence





For each included source of evidence, present the 
relevant data that were charted that relate to the 




Summarize and/or present the charting results as 
they relate to the review questions and objectives.
9 to 16 and 




Summarize the main results (including an 
overview of concepts, themes, and types of 
evidenc  available), link to the review questions 
and objectives, and consider the relevance to key 
groups.
16 -18
Limitations 20 Discuss the limitations of the scoping review process. 16 -18
Conclusions 21
Provide a general interpretation of the results with 
respect to the review questions and objectives, as 




Describe sources of funding for the included 
sources of evidence, as well as sources of funding 
for the scoping review. Describe the role of the 
funders of the scoping review.
NA
JBI = Joanna Briggs Institute; PRISMA-ScR = Preferred Reporting Items for Systematic reviews and Meta-
Analyses extension for Scoping Reviews.
* Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social 
media platforms, and Web sites.
† A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g., 
quantitative and/or qualitative research, expert opinion, and policy documents) that may be eligible in a scoping 
review as opposed to only studies. This is not to be confused with information sources (see first footnote).
‡ The frameworks by Arksey and O’Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 5) refer to 
the process of data extraction in a scoping review as data charting.
§ The process of systematically examining research evidence to assess its validity, results, and relevance before 
using it to inform a decision. This term is used for items 12 and 19 instead of "risk of bias" (which is more 
applicable to systematic reviews of interventions) to include and acknowledge the various sources of evidence 
that may be used in a scoping review (e.g., quantitative and/or qualitative research, expert opinion, and policy 
document).
From: Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist 
and Explanation. Ann Intern Med. ;169:467–473. doi: 10.7326/M18-0850
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EUPD and EEG: Checklist and Questions for EEG Findings.
Questions For Findings in QEEG/ Digital EEG. 
(Examine the Z-score tables for the distribution of abnormalities) 
1) Does the QEEG/Digital EEG show presence of Interhemispheric and Intrahemispheric 
Coherence. 
(a) Greater left cortical activation (EUPD).
(b) Greater right cortical activation (Major Depression).
(c) Significant delay in early posterior gamma* synchrony & reduced right hemisphere late 
gamma synchrony.
(d) Delay in posterior gamma synchrony associated with cognitive symptoms
(e) Reduced right hemisphere gamma synchrony associated with impulsivity
*gamma - (37–41 Hz)
2) What is the Absolute Power in 
(a) delta (<3 Hz)
(b) theta*(4-7 Hz)
(c) alpha (8-12 Hz)
(d) beta (>13 Hz)
* Total theta power higher in EUPD.




(i) Less stable EEG-vigilance pattern ‘A’ with a tendency to drop to lower vigilance states ‘B’
(‘A’= at least one EEG channel shows a relative alpha power >50% compared to the total 
power of the respective channel.
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‘B’=No clear alpha rhythm in any channels)
(d) beta
4) What is the Mean Frequency.
(a)  Does the mean frequency on spectral analysis correlate with anxiety levels.
5) Presence of Asymmetry Values
Questions for Findings in Standard EEG. 
Does the EEG indicate the following?
6) Diffuse slowing
7) Dysrhythmias (EEG cerebral dysrhythmia denotes isolated episodic paroxysmal bursts of 
slow activity, suppression of waveforms, controversial/anomalous spiky waveforms, sharp 
waves and/or true non-controversial epileptiform discharges).
8) Sharp waves, especially in posterior areas
9) Increased slow wave activity
10) 
(a) Increased prevalence of intermittent rhythmic delta (IRDA) or theta (IRTA) activity. 
(b) random or semi-rhythmic theta and/or delta
11) Abnormalities in Temporal lobe areas.
12) Epileptiform patterns
Questions for Findings in Sleep EEG.  
Does the EEG indicate the following?
13) Increased REM percentage
14) Increased REM density
15) Shorter REM latency (much shorter in EUPD with Depression)
16) Longer REM period.
17) Increased delta power in Non-REM sleep.
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18) Reduced slow wave, stage 3 & 4 sleep
Questions for Findings in Evoked Potentials. 
Does the EEG indicate the following?
19) Increased P300 latency
20) Decreased P300 amplitude
21) Increased amplitude of P3a and loss of temporal synchronicity of P3a with P3b.
22) Larger late positive potentials (LPP).
23) Higher loudness dependence of the N1/P2 component of auditory evoked potentials.
24) Reduced P3 amplitudes during No-go responses in Go-No-go test.
25) Smaller LPC amplitude
26) Increase in slow wave frequencies (theta, delta and slow alpha) in the orbital cortex, 
dorsomedial prefrontal or dorsolateral prefrontal cortexes
27) Decreased P300 latency
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Generating the Checklist based on Findings in relevant articles.
Q1-Q25 indicate the question generated based on the individual article findings.
Articles Findings
Beeney et. al. 
2014 (38)
EUPD - greater left cortical 
activation, MDD - greater right 
cortical activation. 
Q1
Russ et. al. 1999 
(39)




Questions for Findings in QEEG/ Digital EEG. 
(Examine the Z-score tables for the distribution of 
abnormalities) 
1. Does the QEEG/Digital EEG show presence of 
Interhemispheric and Intrahemispheric Coherence. 
(a) Greater left cortical activation (EUPD).
(b) Greater right cortical activation (Major 
Depression).
(c) Significant delay in early posterior gamma* 
synchrony & reduced right hemisphere late 
gamma synchrony.
(d) delay in posterior gamma synchrony associated 
with cognitive symptoms
(e) Reduced right hemisphere gamma synchrony 
associated with impulsivity
*gamma - (37–41 Hz)
2. What is the Absolute Power in 
(a) delta (<3Hz)
(b) theta* (4-7Hz)
(c) alpha (8-12 Hz)
(d) beta (>13Hz)
* Total theta power higher in EUPD.
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(i) Less stable EEG-vigilance pattern ‘A’ with a 
tendency to drop to lower vigilance states ‘B’
(‘A’= at least one EEG channel shows a relative 
alpha power >50% compared to the total power of 
the respective channel.
‘B’=No clear alpha rhythm in any channels)
(d) beta
4. What is the Mean Frequency.
(a)  Does the mean frequency on spectral analysis 
correlate with anxiety levels.
5. Presence of Asymmetry Values
Ogiso et al. 1993 
(41)
NONE
De La Fuente, 
1998 (42)
EUPD -diffuse slowing on EEG 
Q6
Cornelius et al. 
1986 (43)
EUPD - EEG dysrhythmias 
Q7
Cowdry et al. 1986 
(44)
EUPD - posterior sharp waves 
Q8
Synder & Pitts, 
1984 (45)
EUPD -Increased slow wave 
activity 
Q9
Hegerl et al. 
2008 (46)
EUPD - less stable EEG-vigilance 
pattern with a tendency to drop 
to lower vigilance states 
(p=0.03). Q3ci
Van Elst, 2016 (47) EUPD - significantly increased 
prevalence of IRDAs and IRTAs 
(intermittent rhythmic delta or 
theta activity)
Questions for Findings in Standard EEG. 
Does the EEG indicate the following?
6. Diffuse slowing
7. Dysrhythmias (EEG cerebral dysrhythmia 
denotes isolated episodic paroxysmal bursts of 
slow activity, suppression of waveforms, 
controversial/anomalous spiky waveforms, sharp 
waves and/or true non-controversial epileptiform 
discharges).
8. Sharp waves, especially in posterior areas
9. Increased slow wave activity
10. 
(a) Increased prevalence of intermittent rhythmic 
delta (IRDA) or theta (IRTA) activity. 
(b) random or semi-rhythmic theta and/or delta
11. CNS abnormalities focal to Temporal lobe 
areas.
12. Epileptiform patterns
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Yerevanian et al. 
1985 (48)
EUPD - EEG abnormalities, most 
commonly in temporal lobe 
areas (abnormalities not 
discussed in detail)
Q11,12
Assad et. al. 2002 
(49)
 EUPD - REM % & REM density 
higher, REM latency shorter, 
longer REM period. (Changes 
less robust than in those with 
depression)
Q13, Q14, Q15, 16
Philipsen et. al. 
2005 (50)
EUPD - Higher delta power in 
NonREM sleep.
Q17
De La Fuente, 
2004 (51)
EUPD -significantly less stage 3 
sleep and slow wave sleep and 
a longer duration of REM sleep.
Q18
De La Fuente, 
2001 (52)
EUPD - longer duration of REM 
sleep, significantly less stage 3, 
stage 4 and slow wave sleep.
Q16, Q18
Battaglia et al. 
1993 (53)
EUPD - Reduced REM latency. 
Q15
Battaglia et al. 
1999 (54)
EUPD - Increased REM density 
in first REM cycle. 
Q14
Bell et al. 1983 
(55)
EUPD patients with depression 
had shorter REM latencies than 
non-depressed EUPD patients. 
Reduced REM latency both 
groups
Q15
Mcnamara et al. 
1984 (56)
EUPD and depressive groups 
both had Shorter REM latency 
and increased REM density.
Q14, Q15
Akiskal et al. 1985 
(57)
EUPD - Shorter REM latency 
than healthy controls and non-
EUPD personality disorder 
patients, but similar results to 
those with affective disorders
Q15
Reynolds et al. 
1985 (58)
EUPD - Reduced REM latency, 
but similar to those with 
depression
Q15
Questions for Findings in Sleep EEG.  
Does the EEG indicate the following?
13. Increased REM percentage
14. Increased REM density
15. Shorter REM latency (much shorter in EUPD 
with Depression)
16. Longer REM period.
17. Increased delta power in Non-REM sleep.
18. Reduced slow wave, stage 3 & 4 sleep
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Blackwood et al. 
1986
EUPD - Longer P300 latency and 
smaller amplitude. 
Q19, Q20
Kutcher et al. 1987 EUPD - Longer P300 latency and 
decreased P300 amplitude.
Q19, Q20
Kutcher et al. 1989 EUPD (BPD) - Prolonged P300 
latency and decreased P300 
amplitude. 
Q19, Q20
Drake et al. 1991 EUPD (BPD) Prolonged P300 
latency and decreased P300 
amplitude.
Q19, Q20
Meares et al. 2004 EUPD (BPD) - Enhanced 
amplitude of P3a and loss of 
temporal synchronicity of P3a 
with P3b. Natural age-related 
decline in P3a amplitude 
reduced in BPD.
Q21
Marissen et al. 
2010
EUPD (BPD) - Larger LPP (late 
positive potentials) to pictures 
with an unpleasant valence.
Q22
He et al, 2012 NONE
Archer et al. 1988 
(66)
NONE
Houston et al. 
2005 (67)
NONE
Houston et al. 
2004 (68)
EUPD - Reduced  P300 
amplitude.
Q20
Questions for Findings in Evoked Potentials. 
Does the EEG indicate the following?
19. Increased P300 latency
20. Decreased P300 amplitude
21. Increased amplitude of P3a and loss of 
temporal synchronicity of P3a with P3b.
22. Larger late positive potentials (LPP).
23. Higher loudness dependence of the N1/P2 
component of auditory evoked potentials.
24. Reduced P3 amplitudes during Nogo responses 
in Go-Nogo test.




Schaaff et al. 2007 
(69)
EUPD - Significantly higher 
loudness dependence of the 
N1/P2 component of auditory 
evoked potentials. Q 23
Cornelius et al. 
1988 (70)
EUPD - Mean frequency on 
spectral analysis correlated with 
anxiety levels. Q4
De La Fuente et al. 
2011 (71)
TSH and standard EEG results 
influence sleep EEG, neurologic 
soft signs and post 
dexamethasone cortisol in 
patients with EUPD . Q6, Q10b
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Ruchsow et al. 
2008 (72)
EUPD - reduced P3 amplitudes 
during Nogo responses in Go-
Nogo test.
Q24
Vega et al. 2017 
(73)
fMRI study, EEG not used/done No EEG findings
Williams et al. 
2006 (74)
EUPD - significant delay in early 
posterior gamma synchrony & 
reduced right hemisphere late 
gamma synchrony. Delay in 
posterior synchrony was 
associated with cognitive 
symptoms and reduced right 
hemisphere synchrony was 
associated with impulsivity.
Q1c, Q1d, Q1e.
Cohen et al. 2016 
(75)
EUPD - Mild to moderate 
increase in slow wave 
frequencies (theta, delta and 
slow alpha) in the orbital cortex, 




26. Increase in slow wave frequencies (theta, delta 
and slow alpha) in the orbital cortex, dorsomedial 
prefrontal or dorsolateral prefrontal cortexes
 (Compare with question 9 & 18)
Brazier et al. 1945 
(76)
Higher incidence of beta activity 
in psychoneurosis versus 
controls (critical ratio 6.54).
No established EUPD diagnosis.
No relevant findings
Hill et al. 2005 (77) EUPD traits - had smaller LPC 
amplitude, decreased P300 
latency, and decreased P300 
amplitudes when making 
incorrect responses to 
emotional pictures and faces. 
Q20, Q25, Q27
27. Decreased P300 latency
Shaofang Xu et al. 
2014 (78)
TRD & GAD - Reduced P3 
amplitude in those with TRD & 
GAD compared to healthy 
controls and those with EUPD. 
EUPD used as control group.
No relevant findings
Teicher et al. 1997 
(29)
No established EUPD diagnosis No relevant findings
Shen et al. 2008 
(79)
NONE No significant findings
Huang-Storms et 
al. 2006 (37)
No established diagnosis No relevant findings
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Table 1.  Articles on the relationship between EEG changes and psychopathology
Paper Type of article Findings
Shelley et al, 2009.7 Review article Higher incidence of EEG abnormalities in 
the nonepileptic neuropsychiatric 
population than the normal population in 
25 out of 29 articles reviewed
Abrams et al, 1980.8 Cross-sectional study Significant correlations between left-sided 
EEG abnormality and formal thought-
disorder and emotional blunting (sample 
size: 159 patients with schizophrenia/ 
affective disorder)
Schoenberg et al, 2014.9 Review article -81% of 63 articles reviewed reported 
clinical amelioration related to 
biofeedback, 65% to a statistically 
significant level (p<0.05) 
-EEG neurofeedback was the most 
investigated modality of biofeedback
-Anxiety disorders were the most 
commonly treated with biofeedback
-Multi-modal biofeedback appeared most 
effective in significantly ameliorating 
symptoms
Small et al, 1984.10 Cohort study EEG abnormalities predicted diagnostic 
change (33% rediagnosed with affective, 
organic or other disorders) & relatively 
favourable prognosis in a sample of 759 
hospitalised patients with schizophrenia
Gallinat et al, 2016.11 Review article -Specific EEG changes in Alzheimers 
disease (increase in delta and theta 
activity, decrease in beta activity, slowing 
of the alpha basal rhythm and reduction 
of the topographical structure) (7 articles 
on Alzheimers disease reviewed)
-EEG changes in delirium (slowing of delta 
and theta activity) (2 articles on delirium 
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- EEG changes specific to Lithium 
intoxication (7 articles), Clozapine (3 
articles) and Benzodiazepines (1 article)
McLoughlin et al, 2013.12 Review article -EEG has improved understanding of face 
processing (3 articles), cognitive control (2 
articles) and mirror neuron activity (1 
article) in the general population.
- Independent component analysis of EEG 
can identify brain sources that correspond 
to distinct suggested emotions (1 article)
Balogh et al, 2010.13 Review article -Patients with a diagnosis of 
schizophrenia, anorexia nervosa or EUPD 
exhibited a decrease in amplitude & those 
with depression and anxiety an increase in 
amplitude of error-negativity (an evoked 
potential component) (number of studies 
reviewed not recorded)
Hughes et al, 1999.14 Review article -EEG and Quantitative EEG changes can be 
seen in anxiety disorder (7 articles), 
depression (27 articles), dementia (62 
articles), obsessive-compulsive disorder (7 
articles), schizophrenia (52 articles) & 
intellectual disabilities or attention deficit 
disorder (20 articles)
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High rate of 



























Page 44 of 66
http://mc.manuscriptcentral.com/eeg






























































































Tukeys HSD = Tukey’s honestly significant difference test, EUPD-P/ EUPD-NP = patients with EUPD 
who are sensitive/ not sensitive to pain following self-injurious activity.
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None for at 
least 7 days
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TCA = Tricyclic antidepressant, MAOI = Monoamine oxidase inhibitors, IRDA/IRTA = intermittent 
rhythmic delta/ theta activity.







































































10 (4/6) None for 
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10 (4/6) None for 






































8 (NR) NR Depression 
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Table 6. Articles meeting 3 Criteria 
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Table 7. Articles meeting 3 Criteria 




































































s et al. 
2006.81






















Page 59 of 66
http://mc.manuscriptcentral.com/eeg
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Table 8. Articles meeting 3 Criteria. 






























QEEG – 19 
sensor 
instrument 
Page 62 of 66
http://mc.manuscriptcentral.com/eeg

























































































Page 63 of 66
http://mc.manuscriptcentral.com/eeg






























































Table 9. Articles meeting 3 Criteria. 
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Table 10. Articles meeting 3 Criteria. 
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Abnormalities found on standard EEGs in EUPD
1. Posterior sharp waves. [55]
2.  Increased slow wave activity.[56]
3. Less stable EEG vigilance patterns.[57]
4. Increased prevalence of intermittent rhythmic delta & theta activity[58]
5. Delay in early posterior gamma synchrony & a reduction in right hemisphere late gamma 
synchrony in response to salient stimuli[83]
Table 12. 
Embase Final Search 2817
PsycInfo Final Search 1123
Medline Final Search 1310
NHS Evidence Final Search 0
Cochrane Final Search 0
JB Final Search 0
Open Grey Final Search 1
Clinical Trials Final Search 6
UK Clinical Trials gateway Final Search 0
EU Clinical Trials Register Final Search 0
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